FDA Inspection
Fisiopharma SrlFisiopharma Srl – FDA Inspection, Sep 27, 2019
Record Details
This FDA Inspection record concerns Fisiopharma Srl, with an inspection on September 27, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · eaeb6742-08ae-454e-8002-d15ee6fb026f
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1107133
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
11- 21 CFR 211.65(a)Equipment construction - reactive surfaces
- 21 CFR 211.84(d)(2)Establish reliability of supplier"s C of A
- 21 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.42(c)Defined areas of adequate size for operations
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.180(e)(2)Items to cover on annual reviews
Showing 10 of 11 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Fisiopharma Srl
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 21, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 26, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fisiopharma Srl
- FDA Inspection 1176478 - 2022-06-21
- FDA Inspection 988928 - 2016-09-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.